Advanced glycation end-product N e{open}-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes

Atherosclerosis

Volumn 221, Issue 2, 2012, Pages 387-396

  Wang, Zhongqun ^a   Jiang, Yicheng ^b   Liu, Naifeng ^a   Ren, Liqun ^a   Zhu, Yinghong ^a   An, Yanli ^c   Chen, Dengyu ^c  

^a SOUTHEAST UNIVERSITY   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

Author keywords

Advanced glycation end products; Apoptosis; Atherosclerosis; Diabetes; Phenotype transformation; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; COLLAGEN; GLUCOSE; STREPTOZOCIN; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; AORTA WALL; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL EMBOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE COURSE; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIPID DIET; MACROPHAGE; MALE; MORPHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING;

ALKALINE PHOSPHATASE; ANIMALS; APOLIPOPROTEINS E; APOPTOSIS; ATHEROSCLEROSIS; BLOTTING, WESTERN; BONE MORPHOGENETIC PROTEIN 2; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC ANGIOPATHIES; DIET, HIGH-FAT; DISEASE PROGRESSION; GLUCOSE; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENOUS; LIPOPROTEINS, LDL; LYSINE; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOGENESIS; RATS; RECEPTORS, IMMUNOLOGIC; STAINING AND LABELING; TIME FACTORS; VASCULAR CALCIFICATION;

EID: 84862802237     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2012.01.019     Document Type: Article

References (38)

1. Yang W., Lu J., Weng J., et al. Prevalence of diabetes among men and women in China. New Engl J Med 2010, 362:1090-1101.
2. Weng J., Bi Y. Diabetes in China: the challenge now. J Diabetes Invest 2010, 1:170-171.
3. D'Souza A., Hussain M., Howarth F.C., et al. Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart. Mol Cell Biochem 2009, 331:89-116.
4. Ehara S., Kobayashi Y., Yoshiyama M., et al. Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study. Circulation 2004, 110:3424-3429.
5. Abedin M., Tintut Y., Demer L.L. Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol 2004, 24:1161-1170.
6. Fitzgerald P.J., Ports T.A., Yock P.G. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation 1992, 86:64-70.
7. Singh R., Barden A., Mori T., et al. Advanced glycation end-products: a review. Diabetologia 2001, 44:129-146.
8. Takeuchi M., Yamagishi S. Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease. J Alzheimers Dis 2009, 16:845-858.
9. Yamagishi S. Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes. Exp Gerontol 2011, 46(4):217-224.
10. Ren X., Shao H., Wei Q., et al. Advanced glycation end-products enhance calcification in vascular smooth muscle cells. J Int Med Res 2009, 37:847-854.
11. Yamagishi S., Matsui T. Smooth muscle cell pathophysiology and advanced glycation end products (AGEs). Curr Drug Targets 2010, 11:875-881.
12. Forbes J.M., Yee L.T., Thallas V., et al. Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 2004, 53:1813-1823.
13. Taki K., Takayama F., Tsuruta Y., et al. Oxidative stress, advanced glycation end product, and coronary artery calcification in hemodialysis patients. Kidney Int 2006, 70:218-224.
14. Kakuta T., Tanaka R., Hyodo T., et al. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients. Am J Kidney Dis 2011, 57:422-431.
15. Conway B., Edmundowicz D., Matter N., et al. Skin fluorescence correlates strongly with coronary artery calcification severity in type 1 diabetes. Diabetes Technol Ther 2010, 12:339-345.
16. Tanikawa T., Okada Y., Tanikawa R., et al. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res 2009, 46:572-580.
17. Hashimoto S., Ochs R.L., Rosen F., et al. Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci USA 1998, 95:3094-3099.
18. Duan X., Zhou Y., Teng X., et al. Endoplasmic reticulum stress-mediated apoptosis is activated in vascular calcification. Biochem Biophys Res Commun 2009, 387:694-699.
19. Uribarri J., Cai W., Sandu O., et al. Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects. Ann N Y Acad Sci 2005, 1043:461-466.
20. Sun Z., Liu J., Zeng X., et al. Protective actions of microalgae against endogenous and exogenous advanced glycation endproducts (AGEs) in human retinal pigment epithelial cells. Food Funct 2011, 2:251-258.
21. Vlassara H., Uribarri J. Glycoxidation and diabetic complications: modern lessons and a warning. Rev Endocr Metab Disord 2004, 5:181-188.
22. Semba R.D., Arab L., Sun K., et al. Fat mass is inversely associated with serum carboxymethyl-lysine, an advanced glycation end product, in adults. J Nutr 2011, 141:1726-1730.
23. Kasper M., Schieberle P. Labeling studies on the formation pathway of Nepsilon-carboxymethyl lysine in maillard-type reactions. Ann N Y Acad Sci 2005, 1043:59-62.
24. Semba R.D., Bandinelli S., Sun K., et al. Plasma carboxymethyl-lysine, and advanced glycation end product, and all cause and cardiovascular disease mortality in older community-dwelling adults. J Am Geriatr Soc 2009, 57:1874-1880.
25. Johnson R.C., Leopold J.A., Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006, 99:1044-1059.
26. Shao J.S., Cai J., Towler D.A. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006, 26:1423-1430.
27. Demer L.L., Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008, 117:2938-2948.
28. Giachelli C.M. Vascular calcification mechanisms. J Am Soc Nephrol 2004, 15:2959-2964.
29. Proudfoot D., Skepper J.N., Hegyi L., et al. Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000, 87:1055-1062.
30. Tabas I. Macrophage apoptosis in atherosclerosis: consequences on plaque progression and the role of endoplasmic reticulum stress. Antioxid Redox Signal 2009, 11:2333-2339.
31. Hegyi L., Hardwick S.J., Siow R.C., et al. Macrophage death and the role of apoptosis in human atherosclerosis. J Hematother Stem Cell Res 2001, 10:27-42.
32. Iyemere V.P., Proudfoot D., Weissberg P.L., et al. Vascular smooth muscle cell phenotypic plasticity and the regulation of vascular calcification. J Intern Med 2006, 260:192-210.
33. Suga T., Iso T., Shimizu T., et al. Activation of receptor for advanced glycation end products induces osteogenic differentiation of vascular smooth muscle cells. J Atheroscler Thromb 2011, 18:670-683.
34. Soro-Paavonen A., Watson A.M., Li J., et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes 2008, 57:2461-2469.
35. Morris-Rosenfeld S., Blessing E., Preusch M.R., et al. Deletion of bone marrow-derived receptor for advanced glycation end products inhibits atherosclerotic plaque progression. Eur J Clin Invest 2011, 41:1164-1171.
36. 1-/- mice. J Vasc Res 2011, 48:227-235.
37. Wu C.J., Lu H.K. Smad signal pathway in BMP-2-induced osteogenesis-a mini review. J Dent Sci 2008, 3:13-21.
38. Ryoo H.M., Lee M.H., Kim Y.J. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene 2006, 366:51-57.